Legend Biotech Corp Increase Through New Leases Liabilities Arising From Financing Activities
Legend Biotech Corp (LEGN) reported Increase Through New Leases Liabilities Arising From Financing Activities of $26.70 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-19.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities · last filed 2025-03-11
| Period end | Increase Through New Leases Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2023-12-31 | $26.70M 20-F · filed 2024-03-19 |
| 2022-12-31 | $23.70M 20-F · filed 2025-03-11 |
| 2021-12-31 | $700.00K 20-F · filed 2024-03-19 |